Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers' Case-Control Study.

MLA

García-Lluch, Gemma, et al. “Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers’ Case-Control Study.” Pharmaceutics, vol. 15, no. 3, Mar. 2023, p. 924. EBSCOhost, https://doi.org/10.3390/pharmaceutics15030924.

APA

García-Lluch, G., Peña-Bautista, C., Royo, L. M., Baquero, M., Cañada-Martínez, A. J., & Cháfer-Pericás, C. (2023). Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers’ Case-Control Study. Pharmaceutics, 15(3), 924. https://doi.org/10.3390/pharmaceutics15030924

Chicago

García-Lluch, Gemma, Carmen Peña-Bautista, Lucrecia Moreno Royo, Miguel Baquero, Antonio José Cañada-Martínez, and Consuelo Cháfer-Pericás. 2023. “Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers’ Case-Control Study.” Pharmaceutics 15 (3): 924. doi:10.3390/pharmaceutics15030924.